Mitochondria and programmed cell death: back to the future

Programmed cell death, or apoptosis, has in the past few years undoubtedly become one of the most intensively investigated biological processes. However, fundamental questions concerning the molecular and biochemical mechanisms remain to be elucidated. The central question concerns the biochemical steps shared by the numerous death induction pathways elicited by different stimuli. Heterogeneous death signals precede a common effector phase during which cells pass a threshold of ‘no return’ and are engaged in a degradation phase where they acquire the typical onset of late apoptosis. Alterations in mitochondrial permeability transition linked to membrane potential disruption precede nuclear and plasma membrane changes. In vitro induction of permeability transition in isolated mitochondria provokes the release of a protein factor capable of inducing nuclear chromatin condensation and fragmentation. This permeability transition is regulated by multiple endogenous effectors, including members of the bcl‐2 gene family. Inhibition of these effects prevents apoptosis.

[1]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[2]  M. Raff,et al.  Programmed cell death and Bcl-2 protection in very low oxygen , 1995, Nature.

[3]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[4]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[5]  G. Kroemer,et al.  Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. , 1995, Blood.

[6]  W. Fiers,et al.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y. Tsujimoto,et al.  Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL , 1995, Nature.

[8]  G. Gores,et al.  The role of proteases during apoptosis , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. Kroemer,et al.  Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo , 1995, European journal of immunology.

[10]  R. Heller,et al.  Tumor necrosis factor receptor-mediated signaling pathways , 1994, The Journal of cell biology.

[11]  R. Muschel,et al.  Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. , 1995, Cancer research.

[12]  M. Parker,et al.  Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. , 1993, Trends in biochemical sciences.

[13]  J. Yodoi,et al.  Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. , 1995, Journal of immunology.

[14]  Guido Kroemer,et al.  The biochemistry of programmed cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  T. Deckwerth,et al.  Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor , 1993, The Journal of cell biology.

[16]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[17]  John Calvin Reed,et al.  Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA , 1993, Nature.

[18]  J. Lancaster,et al.  Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor , 1989, FEBS letters.

[19]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[20]  R. Meadows,et al.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.

[21]  M. Zoratti,et al.  Electrophysiology of the inner mitochondrial membrane , 1994, Journal of bioenergetics and biomembranes.

[22]  H. Horvitz,et al.  C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.

[23]  E. Alnemri,et al.  Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Fiers,et al.  Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.

[25]  J. M. Boyd,et al.  Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. , 1995, Oncogene.

[26]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. , 1979, Archives of biochemistry and biophysics.

[27]  J. Ameisen The Origin of Programmed Cell Death , 1996, Science.

[28]  T. Gunter,et al.  Mechanisms by which mitochondria transport calcium. , 1990, The American journal of physiology.

[29]  G. Rödel,et al.  A fluorescence-microscopic and flow-cytometric study of HeLa cells with an experimentally induced respiratory deficiency. , 1992, Biochemical and biophysical research communications.

[30]  S. Nordeen,et al.  Glucocorticoid action on rat thymic lymphocytes. Experiments utilizing adenosine to support cellular metabolism lead to a reassessment of catabolic hormone actions. , 1976, The Journal of biological chemistry.

[31]  G. Kroemer,et al.  Effects of Mycoplasma fermentans on the myelomonocytic lineage. Different molecular entities with cytokine-inducing and cytocidal potential. , 1996, Journal of immunology.

[32]  D. Adams,et al.  Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells , 1993, The Journal of experimental medicine.

[33]  R. T. Carroll,et al.  IL-1 beta converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line. , 1995, Journal of immunology.

[34]  P. Amiri,et al.  Requirement of an ICE-Like Protease for Induction of Apoptosis and Ceramide Generation by REAPER , 1996, Science.

[35]  David L. Vaux,et al.  An evolutionary perspective on apoptosis , 1994, Cell.

[36]  G. Kroemer,et al.  Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.

[37]  P. Bernardi,et al.  Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane , 1994, Journal of bioenergetics and biomembranes.

[38]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[39]  P. Henkart ICE family proteases: mediators of all apoptotic cell death? , 1996, Immunity.

[40]  E. London,et al.  Diphtheria toxin: membrane interaction and membrane translocation. , 1992, Biochimica et biophysica acta.

[41]  G. Cohen,et al.  A role for metals and free radicals in the induction of apoptosis in thymocytes , 1994, FEBS letters.

[42]  W. Greenhalf,et al.  Role of mitochondria and C‐terminal membrane anchor of Bcl‐2 in Bax induced growth arrest and mortality in Saccharomyces cerevisiae , 1996, FEBS letters.

[43]  K. Schulze-Osthoff,et al.  Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. , 1994, The EMBO journal.

[44]  P. Petit,et al.  Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis , 1995, The Journal of cell biology.

[45]  T. Komiyama,et al.  Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. , 1994, The Journal of biological chemistry.

[46]  R. Zamoyska,et al.  Anti‐CD3‐induced cell death in T cell hybridomas: mitochondrial failure and DNA fragmentation are distinct events , 1991, European journal of immunology.

[47]  V. Skulachev Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants , 1996, Quarterly Reviews of Biophysics.

[48]  Z. Oltvai,et al.  BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.

[49]  S. Korsmeyer,et al.  Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. , 1993, The Journal of biological chemistry.

[50]  T. Hennet,et al.  Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. , 1993, Cancer research.

[51]  M. Jacobson Reactive oxygen species and programmed cell death. , 1996, Trends in biochemical sciences.

[52]  Y. Lazebnik,et al.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.

[53]  E. Alnemri,et al.  Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.

[54]  C. Franceschi,et al.  Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. , 1995, Experimental cell research.

[55]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[56]  B. Chernyak,et al.  Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites (*) , 1996, The Journal of Biological Chemistry.

[57]  M. Raff,et al.  Programmed cell death and Bcl‐2 protection in the absence of a nucleus. , 1994, The EMBO journal.

[58]  T. Chittenden,et al.  A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.

[59]  N. Davidson,et al.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.

[60]  John Calvin Reed Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[61]  W. Fiers,et al.  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.

[62]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[63]  T. Buttke,et al.  Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.

[64]  T. Murphy,et al.  Rapid Communication: Oxidative Stress Induces Apoptosis in Embryonic Cortical Neurons , 1994, Journal of neurochemistry.

[65]  D. Newmeyer,et al.  Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria , 1994, Cell.

[66]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[67]  D. Green,et al.  Dicing with death: dissecting the components of the apoptosis machinery. , 1994, Trends in biochemical sciences.

[68]  L. Gooding,et al.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. , 1988, Journal of immunology.

[69]  P. Barr,et al.  Apoptosis and Its Role in Human Disease , 1994, Bio/Technology.

[70]  P. Petit,et al.  Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Kroemer,et al.  Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. , 1996, Cancer research.

[72]  Z. Oltvai,et al.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Cleary,et al.  The bcl-2 protein is inserted into the outer membrane but not into the inner membrane of rat liver mitochondria in vitro. , 1993, Biochemical and biophysical research communications.

[74]  R. Black,et al.  Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[75]  G. Fröschl,et al.  Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase , 1994, The Journal of cell biology.

[76]  Sharad Kumar,et al.  ICE-like proteases in apoptosis. , 1995, Trends in biochemical sciences.

[77]  Z. Darżynkiewicz,et al.  Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes. , 1992, Leukemia.

[78]  G. Cohen,et al.  An interleukin‐1β‐converting enzyme‐like protease is a common mediator of apoptosis in thymocytes , 1995, FEBS letters.

[79]  P. Tosi,et al.  Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy. , 1995, Experimental cell research.

[80]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[81]  M. Mannie,et al.  Inhibition of activation‐induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis , 1994, Journal of leukocyte biology.

[82]  G. Kroemer,et al.  Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo , 1995, The Journal of experimental medicine.